Vulvovaginal candidiasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Clinical study results of patients who simultaneously meet the above-mentioned integrated Chinese and Western medicine diagnostic criteria for vulvovaginal candidiasis. (2) Vulvovaginal Candidiasis score < 7; (3) Female patients aged 18–45 years with a history of sexual activity and regular menstrual cycles; (4) No treatment with antibiotics or antifungal agents within the past two weeks; (5) Patients who provided informed consent and were able to cooperate with the treatment and follow-up of this trial.
Exclusion criteria
Exclusion criteria: (1) Patients complicated with other infectious diseases of the vulva and vagina. (2) Patients with a Vulvovaginal Candidiasis score = 7. (3) Patients complicated with diabetes mellitus or other severe primary diseases of the heart, liver, kidney, etc. (4) Patients who meet the age criteria but deny a history of sexual activity. (5) Patients who have taken relevant medications or received treatment for this disease within 2 weeks prior to enrollment. (6) Patients planning for pregnancy, pregnant women, or lactating women. (7) Patients with hypersensitivity to the drugs used in this trial or to multiple drugs.(8) Patients with an unhealthy lifestyle or consumption of spicy and irritating foods during treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time for symptom improvement;Changes in vaginal microecology;Vulvovaginal Candidiasis recurrence rate 1, 2, 3 months after stopping medication; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vulvovaginal Candidiasis score;Therapeutic efficacy of Traditional Chinese Medicine syndromes; | — |
Countries
China
Contacts
The First Affiliated Hospital of Henan University of Chinese Medicine